Question 1

What is ataxia-telangiectasia-like disorder 2?

Accepted Answer

Ataxia-telangiectasia-like disorder 2 is a very rare inherited condition that primarily affects neurological development and multiple body systems. It is characterized by features such as ataxia, cerebellar atrophy, cutaneous photosensitivity, and telangiectasia, with affected individuals also often experiencing global developmental delay. Variants in the PCNA gene are responsible for the condition, which is inherited in an autosomal recessive pattern. Because it occurs in fewer than 1 in 1 million people, recognition of the syndrome is critical for appropriate management and family counseling.

Question 2

What are the symptoms of ataxia-telangiectasia-like disorder 2?

Accepted Answer

The clinical presentation of ataxia-telangiectasia-like disorder 2 is defined by a constellation of findings present in most affected individuals. Characteristic features include short stature, cutaneous photosensitivity, cerebellar atrophy, ataxia, and cutaneous telangiectasia, in addition to neurodegeneration and sensorineural hearing impairment which point to involvement of central nervous system pathways. Global developmental delay is universally observed, and many patients also experience photophobia and an unsteady gait. In a subset of individuals, features such as progeroid facial appearance, conjunctival telangiectasia, microcephaly, and an absent pubertal growth spurt may be present, with joint contractures or even congenital diaphragmatic hernia being less common. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes ataxia-telangiectasia-like disorder 2?

Accepted Answer

Ataxia-telangiectasia-like disorder 2 results from pathogenic variants in the PCNA gene. PCNA plays a critical role in DNA replication and repair, and disruption of its function leads to the clinical manifestations observed in this condition. It is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the altered gene to be affected. This condition is more common when parents share a common ancestor, as both are then more likely to carry the same rare genetic variant. Genetic counseling is recommended to help affected families understand these implications. Associated genes include PCNA.

Question 4

How is ataxia-telangiectasia-like disorder 2 inherited?

Accepted Answer

ataxia-telangiectasia-like disorder 2 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is ataxia-telangiectasia-like disorder 2?

Accepted Answer

ataxia-telangiectasia-like disorder 2 is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is ataxia-telangiectasia-like disorder 2 diagnosed?

Accepted Answer

Diagnosis is confirmed through molecular genetic testing that identifies pathogenic variants in the PCNA gene. In addition, clinical evaluation, including assessment of the characteristic findings such as cerebellar atrophy, ataxia, photosensitivity, and developmental delay, is essential. As many of these features can overlap with other conditions, genetic testing plays a key role in distinguishing this disorder from similar presentations.

Question 7

Are there treatments for ataxia-telangiectasia-like disorder 2?

Accepted Answer

Currently, management focuses on supportive care and symptom relief. Treatment is tailored to the individual and typically involves a multidisciplinary team to address the neurological, dermatological, and developmental aspects of the disorder. Regular surveillance is an essential part of long-term care, helping to identify potential complications before they become serious. Patients should discuss treatment options with their healthcare team to determine which therapies may be appropriate for their specific situation, and genetic counseling is recommended for families.

Question 8

Are there clinical trials for ataxia-telangiectasia-like disorder 2?

Accepted Answer

Yes, there is currently 1 active clinical trial for ataxia-telangiectasia-like disorder 2 registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 9

What complications can arise from ataxia-telangiectasia-like disorder 2?

Accepted Answer

Complications from ataxia-telangiectasia-like disorder 2 can include progressive neurodegeneration and motor decline as individuals age. Some patients may also experience developmental challenges early in life. Regular check-ups and monitoring can help catch any complications early, allowing for better management.

Question 10

How does ataxia-telangiectasia-like disorder 2 affect daily life?

Accepted Answer

Daily life for individuals with ataxia-telangiectasia-like disorder 2 can be impacted by symptoms like ataxia and developmental delays. This may affect mobility, learning, and social interactions. Supportive care and therapy can help improve daily functioning and quality of life.

Question 11

What is the prognosis for someone with ataxia-telangiectasia-like disorder 2?

Accepted Answer

The prognosis for ataxia-telangiectasia-like disorder 2 varies widely based on symptom severity and access to care. Many individuals can live into adulthood, but some may experience challenges like motor decline over time. It's important for families to work closely with healthcare providers for ongoing support.

Question 12

What specialists should be involved in the care of someone with ataxia-telangiectasia-like disorder 2?

Accepted Answer

Care for ataxia-telangiectasia-like disorder 2 typically involves a multidisciplinary team. This may include neurologists, developmental specialists, and dermatologists to address the various symptoms. Families are encouraged to connect with specialists who understand this rare condition for the best management options.

Kisho

ataxia-telangiectasia-like disorder 2

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

ataxia-telangiectasia-like disorder 2

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is ataxia-telangiectasia-like disorder 2?

What are the symptoms of ataxia-telangiectasia-like disorder 2?

What causes ataxia-telangiectasia-like disorder 2?

How is ataxia-telangiectasia-like disorder 2 inherited?

How rare is ataxia-telangiectasia-like disorder 2?

How is ataxia-telangiectasia-like disorder 2 diagnosed?

Are there treatments for ataxia-telangiectasia-like disorder 2?

Are there clinical trials for ataxia-telangiectasia-like disorder 2?

What complications can arise from ataxia-telangiectasia-like disorder 2?

How does ataxia-telangiectasia-like disorder 2 affect daily life?

What is the prognosis for someone with ataxia-telangiectasia-like disorder 2?

What specialists should be involved in the care of someone with ataxia-telangiectasia-like disorder 2?

Explore clinical features